Somatostatine Belpharma

Somatostatin Belpharma is a synthetic peptide hormone used for short-term treatment of severe diarrhea and flushing in carcinoid tumors and vasoactive intestinal peptide-secreting tumors. It works by reducing hormone secretion. This medication is administered intravenously and requires medical supervision.

Somatostatin Belpharma is primarily used to manage severe diarrhea and flushing associated with carcinoid tumors and vasoactive intestinal peptide-secreting tumors. It helps control symptoms by inhibiting the release of hormones that cause these conditions. This medication is typically prescribed when other treatments have not been effective.

Somatostatin Belpharma works by slowing down the release of certain hormones in the body, which can reduce symptoms like diarrhea and flushing. Patients may experience improved comfort and fewer episodes of severe symptoms while using this medication. The effects are temporary and require ongoing administration.

Somatostatin Belpharma should only be used under medical supervision due to the need for precise dosing and monitoring. Patients with a history of gallstones or liver disease should inform their healthcare provider before starting this medication. Regular check-ups may be required to assess its effectiveness and safety.

Somatostatin Belpharma may interact with medications that affect blood sugar levels, such as insulin or oral diabetes drugs. It can also interact with drugs that slow heart rate or lower blood pressure. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.